{
    "clinical_study": {
        "@rank": "119513", 
        "arm_group": [
            {
                "arm_group_label": "Unfractionated Heparin", 
                "arm_group_type": "Experimental", 
                "description": "Low dose unfractionated Heparin 10 unit/kgBW/hour continuous infusion"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Normal saline packed in same form with trial drugs."
            }
        ], 
        "brief_summary": {
            "textblock": "Sepsis is a clinical syndrome which infection trigger systemic inflammatory response.\n      Uncontrolled inflammatory process leads to multiple organ dysfunction and cause early\n      mortality in severe sepsis. Unfractionated heparin is anticoagulant that widely used either\n      for  DVT prophylaxis and treatment of disseminated intravascular coagulation. Heparin also\n      have anti inflammatory effect trough downregulates nuclear factor kappa B and tumor necrosis\n      factor alpha.\n\n      Aim of this study is to determine effects of low dose unfractionated heparin treatment on\n      inflammation in severe sepsis patient."
        }, 
        "brief_title": "Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Severe Sepsis With Septic Shock", 
            "Severe Sepsis Without Septic Shock"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Sepsis", 
                "Toxemia", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with severe sepsis and septic shock define by revised Sepsis Criteria (2001)\n\n          -  Within 48 hour diagnose sepsis\n\n          -  Agree to participate\n\n        Exclusion Criteria:\n\n          -  Pregnancy and lactation\n\n          -  Severe thrombocytopenia, platelet less than 30.000/mm3\n\n          -  Bleeding or high risk of major bleeding\n\n          -  During anticoagulant treatment\n\n          -  After thrombolytic treatment\n\n          -  Decompensated chronic liver diseases\n\n          -  Chronic kidney diseases on dialysis treatment\n\n          -  During high dose corticosteroid treatment\n\n          -  HIV with CD4 count below 50/mm3\n\n          -  Indication for high dose heparin treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135770", 
            "org_study_id": "HLDS01"
        }, 
        "intervention": {
            "arm_group_label": "Unfractionated Heparin", 
            "description": "10 unit/kgBW/hour continuous infusion for 72 hours", 
            "intervention_name": "Unfractionated heparin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Calcium heparin", 
                "Heparin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "heparin", 
            "sepsis", 
            "inflammation"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "location": {
            "contact": {
                "email": "chen_tropik@hotmail.com", 
                "last_name": "Khie Chen Lie, MD", 
                "phone": "+62213904190"
            }, 
            "facility": {
                "address": {
                    "city": "Jakarta", 
                    "country": "Indonesia", 
                    "zip": "10430"
                }, 
                "name": "Dr. Cipto Mangunkusumo General Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Indonesia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Control Trial to Assessed the Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Severe Sepsis", 
        "overall_contact": {
            "email": "chen_tropik@hotmail.com", 
            "last_name": "Khie Chen Lie, MD", 
            "phone": "+62213904190"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Indonesia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "determine effects of low dose unfractionated heparin treatment on  nuclear factor kappa B, inhibitor kappa B kinase  and tumor necrosis factor-alpha.", 
            "measure": "inflammation", 
            "safety_issue": "No", 
            "time_frame": "3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135770"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Indonesia University", 
            "investigator_full_name": "Khie Chen Lie", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "determine impact of low dose unfractionated heparin on mortality and improvement APACHE II score", 
            "measure": "clinical outcome", 
            "safety_issue": "Yes", 
            "time_frame": "14 days"
        }, 
        "source": "Indonesia University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Indonesia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}